Latest filing published 12 Jan 2022 for Neogenomics INC, €17k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Kathryn B. McKenzie: trading record in brief
This profile gathers the share dealings of Kathryn B. McKenzie in Neogenomics Inc, where the filings describe the role as finance chief. Between 1 March 2019 and 11 January 2022, the trades on record add up to 12 filings.
The open-market record consists of 2 sales worth €248k, with no purchase. The rest of the record consists of 7 share grants and 3 option exercises.
The latest filing, published on 12 January 2022, reports an option exercise of €17k in Neogenomics Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kathryn B. McKenzie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,100 shares@ US$9.0722.7% of flowCommon StockSEC:0001077183-22-000002:0
- 30,572 shares0Common StockSEC:0001077183-21-000276:0
- 1,846 shares@ US$35.0077.3% of flowCommon StockSEC:0001077183-21-000260:0
3 of 3 declarations
